Revised full year forecast FY16
An update on the Group’s revenue and operating earnings forecast for FY16 was provided on 18 December 2015. The Company has since delivered a strong first half and an exceptional performance in January. Based on this, and our assessment of the reasonable risks relating to potential changes in infant formula regulations, the Company has determined it appropriate to further revise its full year outlook upward. Group revenue is now forecast to be in the range of $335 million to $350 million and Group operating EBITDA in the range of $45 million to $49 million for the 2016 financial year5 .
That's what we needed
A2M 17th $2 +, page-461
-
- There are more pages in this discussion • 132 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.02 |
Change
0.170(2.48%) |
Mkt cap ! $5.075B | |||
| Open | High | Low | Value | Volume |
| $6.86 | $7.03 | $6.81 | $16.52M | 2.369M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10280 | $7.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.02 | 17972 | 4 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |